ORGANOGENESIS HOLDINGS INC.

Analyst Reco. Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
2.49 ^USD	0.00%		+8.97%	-39.12%

May. 02	Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis	CI
Feb. 29	Transcript : Organogenesis Holdings Inc., Q4 2023 Earnings Call, Feb 29, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BTIG Raises Price Target on Organogenesis Holdings to $6 From $4, Keeps Buy Rating	Dec. 27	MT
Morgan Stanley Adjusts Price Target on Organogenesis to $3.50 From $3, Maintains Equalweight Rating	Nov. 14	MT
Hopes of rate peak, China turnaround lift stocks	23-09-04	AN
Morgan Stanley Adjusts Price Target on Organogenesis Holdings to $3 From $5, Maintains Equal-Weight Rating	23-08-11	MT
Morgan Stanley Starts Organogenesis Holdings at Equalweight With $5 Price Target	23-06-15	MT
BTIG Upgrades Organogenesis to Buy From Neutral, Price Target is $10	23-05-24	MT
BTIG Downgrades Organogenesis Holdings to Neutral From Buy	22-11-10	MT
Oppenheimer Downgrades Organogenesis Holdings to Perform From Outperform, Removes $14 Price Target	22-08-10	MT
SVB Leerink Adjusts Organogenesis Holdings' Price Target to $20 from $26, Keeps Outperform Rating	21-11-10	MT
ORGANOGENESIS : Oppenheimer Adjusts Organogenesis Holdings PT to $28 From $25 on Strong Q1 Beat and Raised Guidance, Maintains Outperform Rating	21-05-11	MT
ORGANOGENESIS : Oppenheimer Adjusts Price Target on Organogenesis Holdings to $25 From $21, Keeps Outperform Rating	21-04-21	MT
ORGANOGENESIS : SVB Leerink Adjusts Price Target on Organogenesis Holdings to $22 From $19, Maintains Outperform Rating	21-03-17	MT
ORGANOGENESIS : Credit Suisse Raises Organogenesis Holdings' PT to $21 from $9, Expects Continued Success of Commercial Execution Strategy; Keeps Outperform Rating	21-03-12	MT
ORGANOGENESIS : SVB Leerink Adjusts Organogenesis Holdings' Price Target to $13 From $10, Keeps at Outperform	21-01-20	MT
ORGANOGENESIS : Oppenheimer Adjusts Price Target on Organogenesis Holdings to $13 From $9, Maintains Outperform Rating	21-01-15	MT
ORGANOGENESIS : Credit Suisse Adjusts Organogenesis Holdings' Price Target to $9 from $8, Keeps Outperform Rating	21-01-07	MT
ORGANOGENESIS : SVB Leerink Adjusts Organogenesis Holdings' Price Target to $10 From $9, Keeps at Outperform	20-11-18	MT
ORGANOGENESIS : Credit Suisse Adjusts Organogenesis Holdings' Price Target to $8 from $7, Keeps Outperform Rating	20-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer